The Journal of Immunology, Vol 151, Issue 11 6036-6042, Copyright © 1993 by American Association of Immunologists

ARTICLES

Elevation of intracellular cAMP in human T lymphocytes by an anti-CD44 mAb

BL Rothman, N Kennure, KA Kelley, M Katz and TM Aune
Institute of Arthritis and Autoimmunity, Miles Research Center, West Haven, CT 06516.

Regulation of lymphocyte responses to activation of the CD3/TCR complex by other cell surface proteins expressed on lymphocytes is a well established phenomenon. CD44 is an example of such a cell surface protein. Anti-CD44 mAb have been identified which either stimulate or inhibit lymphocyte function. Certain anti-CD44 mAb augment proliferation and IL-2 production by T cells stimulated through the CD2 or CD3/TCR pathways. An anti-CD44 mAb with opposing properties has also been identified. This mAb inhibits activation of human T cells by preventing the rise in [Ca2+]i stimulated by OKT3. The purpose of experiments reported here was to further characterize this phenomenon. The results show that the anti-CD44 mAb, 212.3, does not inhibit inositol phosphate turnover stimulated by OKT3 but does inhibit elevation of intracellular [Ca2+]i in these same cells. Addition of 212.3 to purified human T cells results in a rapid increase in intracellular levels of cAMP. Elevation of cAMP by 212.3 is time- and concentration-dependent. Activation of adenylate cyclase by forskolin also results in elevation of intracellular cAMP and inhibition of the increase in [Ca2+]i stimulated by OKT3. Taken together, these data suggest that CD44 may be positively coupled to adenylate cyclase and that activation of adenylate cyclase by the anti-CD44 mAb, 212.3, may mediate the inhibition of the OKT3-stimulated elevation of [Ca2+]i.

This article has been cited by other articles:

				R. J. McKallip, M. Fisher, U. Gunthert, A. K. Szakal, P. S. Nagarkatti, and M. Nagarkatti Role of CD44 and Its v7 Isoform in Staphylococcal Enterotoxin B-Induced Toxic Shock: CD44 Deficiency on Hepatic Mononuclear Cells Leads to Reduced Activation-Induced Apoptosis That Results in Increased Liver Damage Infect. Immun., January 1, 2005; 73(1): 50 - 61. [Abstract] [Full Text] [PDF]

				Z. Gadhoum, M.-P. Leibovitch, J. Qi, D. Dumenil, L. Durand, S. Leibovitch, and F. Smadja-Joffe CD44: a new means to inhibit acute myeloid leukemia cell proliferation via p27Kip1 Blood, February 1, 2004; 103(3): 1059 - 1068. [Abstract] [Full Text] [PDF]

				R. J. McKallip, Y. Do, M. T. Fisher, J. L. Robertson, P. S. Nagarkatti, and M. Nagarkatti Role of CD44 in activation-induced cell death: CD44-deficient mice exhibit enhanced T cell response to conventional and superantigens Int. Immunol., September 1, 2002; 14(9): 1015 - 1026. [Abstract] [Full Text] [PDF]

				S. Khaldoyanidi, S. Karakhanova, J. Sleeman, P. Herrlich, and H. Ponta CD44 variant-specific antibodies trigger hemopoiesis by selective release of cytokines from bone marrow macrophages Blood, May 13, 2002; 99(11): 3955 - 3961. [Abstract] [Full Text] [PDF]

				A P Cairns, A D Crockard, J R McConnell, P A Courtney, and A L Bell Reduced expression of CD44 on monocytes and neutrophils in systemic lupus erythematosus: relations with apoptotic neutrophils and disease activity Ann Rheum Dis, October 1, 2001; 60(10): 950 - 955. [Abstract] [Full Text] [PDF]

				M. Si-Tahar, S. Sitaraman, T. Shibahara, and J. L. Madara Negative regulation of epithelium-neutrophil interactions via activation of CD44 Am J Physiol Cell Physiol, March 1, 2001; 280(3): C423 - C432. [Abstract] [Full Text] [PDF]

				S. Murakami, T. Saho, A. Asari, E. Hino, D. Kasai, Y. Shimabukuro, and H. Okada CD44-Hyaluronate Interaction Participates in the Adherence of T-lymphocytes to Gingival Fibroblasts Journal of Dental Research, August 1, 1996; 75(8): 1545 - 1552. [Abstract] [PDF]

				C. Isacke The role of the cytoplasmic domain in regulating CD44 function J. Cell Sci., January 9, 1994; 107(9): 2353 - 2359. [PDF]